| MeSH term | MeSH ID | Detail |
|---|---|---|
| Stomach Ulcer | D013276 | 75 associated lipids |
| Stomach Volvulus | D013277 | 1 associated lipids |
| Streptococcal Infections | D013290 | 4 associated lipids |
| Strongyle Infections, Equine | D013319 | 1 associated lipids |
| Subarachnoid Hemorrhage | D013345 | 17 associated lipids |
| Tachycardia | D013610 | 7 associated lipids |
| Tachycardia, Paroxysmal | D013614 | 2 associated lipids |
| Tachycardia, Supraventricular | D013617 | 3 associated lipids |
| Takayasu Arteritis | D013625 | 3 associated lipids |
| Thrombasthenia | D013915 | 4 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schelzig H et al. | Role of recombinant hirudin in a pig-to-human lung transplantation model. | 2002 | Transplant. Proc. | pmid:12270449 |
| Hashimoto T et al. | Experimental study on the relationship between prostaglandin production and acute pancreatic rejection. | 1989 | Transplant. Proc. | pmid:2495617 |
| Alcaraz A et al. | Experimental kidney transplantation in pigs from non-heart-beating donors: evaluation of vasoactive substances and renal artery flow. | 2001 | Transplant. Proc. | pmid:11543815 |
| Shimizu Y et al. | Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation. | 1995 | Transplant. Proc. | pmid:8539906 |
| Odor-Morales A et al. | In vivo thromboxane production by different organs in the rat: its implication in organ transplant failure. | 1987 | Transplant. Proc. | pmid:3617213 |
| Kasahara M et al. | Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models. | 2000 | Transplant. Proc. | pmid:11120230 |
| Odor-Morales A et al. | Increased thromboxane production by the pancreas after 24-hour preservation in UW-1 solution. | 1991 | Transplant. Proc. | pmid:1989317 |
| Kawai T et al. | The changes in prostaglandins after segmental pancreatic transplantation. | 1991 | Transplant. Proc. | pmid:1989318 |
| Santillan-Doherty P et al. | Urinary thromboxane B2 excretion during acute rejection in cyclosporine-treated experimental lung allotransplantation. | 1992 | Transplant. Proc. | pmid:1412957 |
| Su CL et al. | Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats. | 2012 | Transplant. Proc. | pmid:22564588 |
| Pestana M et al. | Kidney graft-infiltrating cells synthesize significantly higher amounts of prostaglandin E2 pre and during acute rejection. | 1999 Feb-Mar | Transplant. Proc. | pmid:10083119 |
| van den Dorpel MA et al. | Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. | 1999 Feb-Mar | Transplant. Proc. | pmid:10083130 |
| Nakache R et al. | Pancreatic juice immunoreactive thromboxane B2 in pancreas allograft rejection. | 1990 | Transplant. Proc. | pmid:1691546 |
| Odor-Morales A et al. | Urinary amylase, urinary insulin, or urinary thromboxane: which is the best predictor of pancreatic allograft rejection in the dog? | 1990 | Transplant. Proc. | pmid:1691549 |
| Lim LK et al. | Fine needle aspiration biopsy, serum beta 2-microglobulin, and urine thromboxane in renal allografts. | 1989 | Transplant. Proc. | pmid:2669249 |
| Odor-Morales A et al. | Urinary thromboxane B2 as indicator of pancreatic allograft rejection in nonimmunosuppressed dogs. | 1989 | Transplant. Proc. | pmid:2669272 |
| Santillan-Doherty P et al. | Thromboxane B2 and lung transplantation: correlation of rejection with levels detected in bronchoalveolar lavage. | 1989 | Transplant. Proc. | pmid:2669273 |
| Zhao Y et al. | Feasibility of serial fine needle aspiration biopsies to monitor dog single lung allografts. | 1989 | Transplant. Proc. | pmid:2669274 |
| Foegh ML et al. | Urine thromboxane as an immunologic monitor in kidney transplant patients. | 1984 | Transplant. Proc. | pmid:6390872 |
| Foegh ML et al. | Monitoring of rat heart allograft rejection by urinary thromboxane. | 1984 | Transplant. Proc. | pmid:6390873 |
| Colomer J et al. | Thromboxane flux and urinary eicosanoids as an index of reperfusion injury in pancreas transplantation after different periods of cold storage. | 1988 | Transplant. Proc. | pmid:3055474 |
| Pittet JF et al. | Protective effect of indomethacin in the development of the postreperfusion syndrome during liver transplantation in pigs. | 1991 | Transplant. Proc. | pmid:1871874 |
| Fukuoka T et al. | Platelet-activating factor as a vasodepressive mediator of liver ischemia. | 1993 | Transplant. Proc. | pmid:8266523 |
| Häyry P et al. | Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. | 1993 | Transplant. Proc. | pmid:8438433 |
| Weir MR et al. | Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans. | 1990 | Transplantation | pmid:2301025 |
| Nassiri M et al. | Lymphoid organ production of immunomodulatory eicosanoids in mice resistant to neonatal tolerance induction. | 1994 | Transplantation | pmid:8009599 |
| Ogata K et al. | Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. | 2001 | Transplantation | pmid:11374398 |
| Lane NJ et al. | Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation. | 1994 | Transplantation | pmid:7809921 |
| Ramos E et al. | The impact of arterialization on prostanoid generation after liver transplantation in the rat. | 1994 | Transplantation | pmid:8042232 |
| Kawaguchi A et al. | Urinary thromboxane excretion in cardiac allograft rejection in immunosuppressed rats. | 1987 | Transplantation | pmid:3547788 |
| Capitanio A et al. | Detection of circulating released platelets after renal transplantation. | 1982 | Transplantation | pmid:6461116 |
| Gibbons CP et al. | Cortical and vascular prostaglandin synthesis during renal allograft rejection in the rat. | 1987 | Transplantation | pmid:3554639 |
| Garvin PJ et al. | Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. | 1996 | Transplantation | pmid:8633364 |
| Markewitz A et al. | Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation. | 1994 | Transplantation | pmid:8154033 |
| Kim YI et al. | Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver. | 1994 | Transplantation | pmid:7940729 |
| Textor SC et al. | Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. | 1993 | Transplantation | pmid:7685934 |
| Petric R et al. | Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition. | 1992 | Transplantation | pmid:1465778 |
| Johnson BF et al. | Urinary thromboxane and 6-keto-prostaglandin F1 alpha are early markers of acute rejection in experimental pancreas transplantation. | 1994 | Transplantation | pmid:7518618 |
| Youngelman DF et al. | Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution. | 1991 | Transplantation | pmid:1994546 |
| Elzinga L et al. | Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine. | 1987 | Transplantation | pmid:3810835 |
| Coffman TM et al. | Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. | 1987 | Transplantation | pmid:3810836 |
| Gladue RP and Newborg MF | The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats. | 1991 | Transplantation | pmid:1949170 |
| Moore TC et al. | Depression of peripheral lymph node lymphocyte traffic in sheep following central venous allogeneic whole-blood transfusion. | 1990 | Transplantation | pmid:1970202 |
| Suckfüll MM et al. | The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. | 1994 | Transplantation | pmid:8310518 |
| Post S et al. | Prostanoid release in experimental liver transplantation. | 1990 | Transplantation | pmid:2316009 |
| Schnabel FR et al. | The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity. | 1991 | Transplantation | pmid:2006526 |
| Ku K et al. | Influences of dietary omega-3 polyunsaturated fatty acids on the recovery of cardiac and renal functions after preservation in hyperlipidemic rats. | 1997 | Transplantation | pmid:9275102 |
| Klassen DK et al. | Effects of cyclosporine on human renal allograft renin and prostaglandin production. | 1989 | Transplantation | pmid:2660347 |
| Ruiz P et al. | Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. | 1988 | Transplantation | pmid:3276038 |
| Pfeiffer S et al. | Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. | 2003 | Transplantation | pmid:12698079 |